volume 108 issue 3 pages 937-952

NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma

Publication typeJournal Article
Publication date2020-08-03
scimago Q1
wos Q2
SJR1.336
CiteScore8.5
Impact factor3.1
ISSN07415400, 19383673
Cell Biology
Immunology
Immunology and Allergy
Abstract
The NLRP3 (NOD-, LRR-, and pyrin domain-containing protein 3) inflammasome is an immunological sensor that detects a wide range of microbial- and host-derived signals. Inflammasome activation results in the release of the potent pro-inflammatory cytokines IL-1β and IL-18 and triggers a form of inflammatory cell death known as pyroptosis. Excessive NLRP3 activity is associated with the pathogenesis of a wide range of inflammatory diseases, thus NLRP3 activation mechanisms are an area of intensive research. NLRP3 inflammasome activation is a tightly regulated process that requires both priming and activation signals. In particular, recent research has highlighted the highly complex nature of the priming step, which involves transcriptional and posttranslational mechanisms, and numerous protein binding partners. This review will describe the current understanding of NLRP3 priming and will discuss the potential opportunities for targeting this process therapeutically to treat NLRP3-associated diseases.
Found 
Found 

Top-30

Journals

2
4
6
8
10
12
14
16
International Journal of Molecular Sciences
15 publications, 7.58%
Frontiers in Immunology
9 publications, 4.55%
International Immunopharmacology
5 publications, 2.53%
Cells
4 publications, 2.02%
Biomedicines
4 publications, 2.02%
Antioxidants
3 publications, 1.52%
Cellular and Molecular Immunology
3 publications, 1.52%
Journal of Experimental Medicine
3 publications, 1.52%
Immunological Reviews
3 publications, 1.52%
Journal of Medicinal Chemistry
3 publications, 1.52%
Biochemical Society Transactions
2 publications, 1.01%
Frontiers in Pharmacology
2 publications, 1.01%
Scientific Reports
2 publications, 1.01%
Cell Death and Differentiation
2 publications, 1.01%
Phytomedicine
2 publications, 1.01%
Journal of Ginseng Research
2 publications, 1.01%
Drug Discovery Today
2 publications, 1.01%
Acta Ophthalmologica
2 publications, 1.01%
Journal of Inflammation Research
2 publications, 1.01%
Oxidative Medicine and Cellular Longevity
2 publications, 1.01%
European Journal of Medicinal Chemistry
2 publications, 1.01%
Frontiers in Physiology
2 publications, 1.01%
Nature Immunology
2 publications, 1.01%
Animals
2 publications, 1.01%
Progress in Retinal and Eye Research
2 publications, 1.01%
Journal of Neuroinflammation
2 publications, 1.01%
European Journal of Pharmacology
2 publications, 1.01%
Cell Death Discovery
2 publications, 1.01%
Wellcome Open Research
1 publication, 0.51%
2
4
6
8
10
12
14
16

Publishers

5
10
15
20
25
30
35
40
45
Elsevier
45 publications, 22.73%
MDPI
32 publications, 16.16%
Springer Nature
32 publications, 16.16%
Frontiers Media S.A.
20 publications, 10.1%
Wiley
13 publications, 6.57%
Cold Spring Harbor Laboratory
11 publications, 5.56%
American Chemical Society (ACS)
6 publications, 3.03%
Taylor & Francis
5 publications, 2.53%
Hindawi Limited
3 publications, 1.52%
Rockefeller University Press
3 publications, 1.52%
Portland Press
2 publications, 1.01%
Oxford University Press
2 publications, 1.01%
European Molecular Biology Organization
2 publications, 1.01%
Spandidos Publications
2 publications, 1.01%
F1000 Research
1 publication, 0.51%
IOS Press
1 publication, 0.51%
Mary Ann Liebert
1 publication, 0.51%
Association for Dental Sciences of the Republic of China
1 publication, 0.51%
Bentham Science Publishers Ltd.
1 publication, 0.51%
American Society for Pharmacology and Experimental Therapeutics
1 publication, 0.51%
SAGE
1 publication, 0.51%
Centre for Evaluation in Education and Science (CEON/CEES)
1 publication, 0.51%
Annual Reviews
1 publication, 0.51%
American Society for Microbiology
1 publication, 0.51%
Ovid Technologies (Wolters Kluwer Health)
1 publication, 0.51%
Association for Research in Vision and Ophthalmology (ARVO)
1 publication, 0.51%
The American Association of Immunologists
1 publication, 0.51%
American Association for the Advancement of Science (AAAS)
1 publication, 0.51%
BMJ
1 publication, 0.51%
5
10
15
20
25
30
35
40
45
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
198
Share
Cite this
GOST |
Cite this
GOST Copy
McKee C. M., Coll R. C. NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma // Journal of Leukocyte Biology. 2020. Vol. 108. No. 3. pp. 937-952.
GOST all authors (up to 50) Copy
McKee C. M., Coll R. C. NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma // Journal of Leukocyte Biology. 2020. Vol. 108. No. 3. pp. 937-952.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1002/jlb.3mr0720-513r
UR - https://doi.org/10.1002/jlb.3mr0720-513r
TI - NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma
T2 - Journal of Leukocyte Biology
AU - McKee, Chloe M.
AU - Coll, Rebecca C.
PY - 2020
DA - 2020/08/03
PB - Wiley
SP - 937-952
IS - 3
VL - 108
PMID - 32745339
SN - 0741-5400
SN - 1938-3673
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2020_McKee,
author = {Chloe M. McKee and Rebecca C. Coll},
title = {NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma},
journal = {Journal of Leukocyte Biology},
year = {2020},
volume = {108},
publisher = {Wiley},
month = {aug},
url = {https://doi.org/10.1002/jlb.3mr0720-513r},
number = {3},
pages = {937--952},
doi = {10.1002/jlb.3mr0720-513r}
}
MLA
Cite this
MLA Copy
McKee, Chloe M., and Rebecca C. Coll. “NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma.” Journal of Leukocyte Biology, vol. 108, no. 3, Aug. 2020, pp. 937-952. https://doi.org/10.1002/jlb.3mr0720-513r.